首页> 外文OA文献 >Lymphedema microsurgical preventive healing approach for primary prevention of lower limb lymphedema after inguinofemoral lymphadenectomy for vulvar cancer.
【2h】

Lymphedema microsurgical preventive healing approach for primary prevention of lower limb lymphedema after inguinofemoral lymphadenectomy for vulvar cancer.

机译:淋巴水肿显微外科手术预防性愈合方法可初步预防股外股本淋巴结切除术治疗外阴癌后下肢淋巴水肿。

摘要

OBJECTIVE: Lower limb lymphedema (LLL) is the most disabling adverse effect of surgical treatment of vulvar cancer. This study describes the use of microsurgical lymphatic venous anastomosis (LVA) to prevent LLL in patients with vulvar cancer undergoing inguinofemoral lymph node dissection (ILND).METHODS: The study included 8 patients with invasive carcinoma of the vulva who underwent unilateral or bilateral ILND. Before incision of the skin in the inguinal region, blue dye was injected in the thigh muscles to identify the lymphatic vessels draining the leg. Lymphatic venous anastomosis was performed by inserting the blue lymphatics coming from the lower limb into one of the collateral branches of the femoral vein (telescopic end-to-end anastomosis). An historical control group of 7 patients, which underwent ILND without LVA, was used as comparison. After 1 month from the surgery, all patients underwent a lymphoscintigraphy.RESULTS: In the study group, 4 patients underwent bilateral ILND, and 4 patients underwent unilateral ILND. Blue-dyed lymphatics and nodes were identified in all patients. It was possible to perform LVA in all the patients. The mean (SD) time required to perform a monolateral LVA was 23.1 (3.6) minutes (range, 17-32 minutes). The mean (SD) follow-up was 16.7 (6.2) months; there was only 1 case of grade 1 lymphedema of the right leg. Lymphoscintigraphic results showed a total mean transport index were 9.08 and 14.54 in the study and the control groups, respectively (P = 0.092).CONCLUSIONS: This study shows for the first time the feasibility of LVA in patients with vulvar cancer undergoing ILND. Future studies including larger series of patients should clarify whether this microsurgical technique reduces the incidence of LLL after ILND.
机译:目的:下肢淋巴水肿(LLL)是外科手术治疗外阴癌最致残的不良反应。这项研究描述了显微外科淋巴静脉吻合术(LVA)预防行腹股沟淋巴结清扫术(ILND)的外阴癌患者的LLL的方法:该研究包括8例行单侧或双侧ILND的外阴浸润性癌患者。在腹股沟区域切开皮肤之前,将蓝色染料注入大腿肌肉中,以识别引流腿部的淋巴管。淋巴静脉吻合术是通过将来自下肢的蓝色淋巴管插入股静脉的一侧支中进行的(望远镜端对端吻合术)。以7例患者的历史对照组作为对照,他们接受了无LVA的ILND治疗。手术1个月后,所有患者均接受了淋巴闪烁显像。结果:研究组中,有4例患者接受了双侧ILND,有4例患者接受了单侧ILND。在所有患者中均发现了蓝染的淋巴管和淋巴结。有可能在所有患者中进行LVA。执行单边LVA所需的平均(SD)时间为23.1(3.6)分钟(范围为17-32分钟)。平均(SD)随访时间为16.7(6.2)个月;右腿只有1例1级淋巴水肿。淋巴造影结果显示,研究和对照组的总平均转运指数分别为9.08和14.54(P = 0.092)。结论:这项研究首次显示了LVA在接受ILND的外阴癌患者中的可行性。包括大量患者在内的进一步研究应阐明这种显微外科手术技术是否可以降低ILND后LLL的发生率。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号